000			02109 a2200685 4500
005			20250513153717.0
264		0	_c19981130
008			199811s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aBenkerrou, M
245	0	0	_aAnti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. _h[electronic resource]
260			_bBlood _cNov 1998
300			_a3137-47 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntibodies, Neoplasm _ximmunology
650	0	4	_aAntibody Specificity
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCD24 Antigen
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aClone Cells _ximmunology
650	0	4	_aCohort Studies
650	0	4	_aEpstein-Barr Virus Infections _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunization, Passive
650	0	4	_aImmunosuppression Therapy _xadverse effects
650	0	4	_aInfant
650	0	4	_aLymphoproliferative Disorders _xetiology
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins
650	0	4	_aMice
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aReceptors, Complement 3d _ximmunology
650	0	4	_aRemission Induction
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aTransplantation _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aJais, J P
700	1		_aLeblond, V
700	1		_aDurandy, A
700	1		_aSutton, L
700	1		_aBordigoni, P
700	1		_aGarnier, J L
700	1		_aLe Bidois, J
700	1		_aLe Deist, F
700	1		_aBlanche, S
700	1		_aFischer, A
773	0		_tBlood _gvol. 92 _gno. 9 _gp. 3137-47
999			_c9751683 _d9751683